Ehave’s Mobile Ketamine Clinic, Rolling into Town.

Longer term, Ehave's (EHVVF) performance has been a quite a disappointment. Investors grew impatient for the launch of one of the most significant advances...

The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma (RDHL), AI Pharma (Private), Apilli Thera...
Psychedelic Stock Review

Coming This Monday..

Microdose's Wonderland: Miami Conference to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 7-9, 2021. Wonderland: Miami Full...

Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Not wanting to be caught flat-footed upon potential approval, Revive is...
Psychedelic Stock Review

Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...

October 26, 2021 07:30 AM Eastern Daylight Time TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics,...

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank's Kevin O'Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr. Sharmin Ghaznavi....

Institutional Analyst, Weekly Newsletter.

- Telehealth Watch List- 2021 Psychedelic Investor Guide out Wednesday.- Report: Ehave Inc (EHVVF) Our Favorite Small Psychedelic Company- Ehave (EHVVF) Announces Inclusion in the...

Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental...

MindMed (MNMD) IPO on Nasdaq: Becomes Second Public Psychedelic Company.

InvestmentU By Amber Deter Apr 27, 2021 at 12:55PM The MindMed IPO is making waves in the news. It will be the second psychedelics company to go public...
Ehave, Psychedelic Stock Review

Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First what it isn’t. In early August our research team conducted...

Latest article

Mitesco Centcore

A Turnaround at Mitesco Coming? Mitesco Moves Into Mini-Data Centers.

Last Round (turnaround that is) worked great, back in 2019, Trading From $0.02 to $0.50. And no, we Didn't Sell a Single Share (waa)....
Dr Sergei Diakov and Roland Rick Perry

Mining Legends: Dr Sergei Diakov

Meet Dr. Sergei Diakov. Most investors have never heard his name, but global mining giants like BHP, Anglo American, and AngloGold Ashanti know exactly...

BCM Resource Corp (B.V), We’re Up 137% in one Week!

Well That's Working out Quite Well.. When we got the news the other day that Mining Legend Dr. Sergei Diakov, reported some rather excellent numbers...